Biotech company Biogen lowered its full-year profit forecast, citing higher costs related to its purchase of drug maker Reata Pharmaceuticals as well as the launch of its Alzheimer's drug.
Share:
More In Business
Bethenny Frankel Talks Sober Curious Trends and Forever Young Rosé
PLUS: the CEO gives advice on navigating the beverage industry and social media.
AI's Impact on School: Enhancing Learning or Fueling Cheating?
McGraw Hill CEO Simon Allen discusses AI tools like AI Reader and Writing Assistant and their effects on learning.
Why the Paralympics Matter: Insights from Gold Medalist Matt Scott
Tune into the Paralympics on NBC and Peacock from August 28th - September 8th!
Calling All College Kids: Cup Noodles' New Flavors & Fantasy Football
Food inflation affects eating and shopping. Students still get bulk deals, but are people trading down? Debate on price gouging and retailer control persists.
Arc'teryx CEO Unpacks The Future Of Sportswear
Arc'teryx CEO Stuart Haselden gives an exclusive look inside the outdoor sportswear brand's new NYC flagship store and introduces new MO/GO wearable hiking tech
Sports and Tech Officially Unite, Driven by A.I.
Key trends include AI, smart stadiums, big tech in streaming, fan engagement, and data-driven marketing.
Fed Rate Cuts: What Will 25-50 Basis Points Mean for Tech and Markets?
Fed rate cuts are near; Dave Harrison Smith explores their impact on tech, markets, and investment strategies.
Tipping Fatigue vs. Tip-Rage: America's Tipping Crisis
Tipping fatigue rises with constant requests, tech, and pandemic shifts. Brooke Masters explores changing perceptions and future trends in tipping.
US Open Returns to NYC: USTA Chair Talks Tennis, Novak, & Alcaraz
The US Open kicks off in NYC, and USTA Chairman Dr. Brian Hainline discusses tennis’s growth, Djokovic's worries about pickleball, and the sport's future.
